0000880771-16-000193.txt : 20160929
0000880771-16-000193.hdr.sgml : 20160929
20160929202017
ACCESSION NUMBER: 0000880771-16-000193
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160929
FILED AS OF DATE: 20160929
DATE AS OF CHANGE: 20160929
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHANG NANCY T
CENTRAL INDEX KEY: 0001135041
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 161911112
MAIL ADDRESS:
STREET 1: 101 WESTCOTT
STREET 2: SUITE 603
CITY: HOUSTON
STATE: TX
ZIP: 77007
4
1
certent-form4.xml
PRIMARY DOCUMENT
X0306
4
2016-09-29
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001135041
CHANG NANCY T
950 TOWER LANE, SUITE 900
FOSTER CITY
CA
94404-2125
1
0
0
0
Common Stock
2016-09-29
4
M
0
7648
5.1
A
36667
D
Common Stock
2016-09-29
4
M
0
33333
5.22
A
70000
D
Non-Qualified Stock Option (right to buy)
5.1
2016-09-29
4
M
0
7648
0
D
2024-06-12
Common Stock
7648
0
D
Non-Qualified Stock Option (right to buy)
5.22
2016-09-29
4
M
0
33333
0
D
2023-06-17
Common Stock
33333
0
D
Granted under the Issuer's 2005 Equity Incentive Plan.
Each option shall vest and become exercisable at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant except that, in the event of a change in control, any unexercisable or unvested portions of outstanding options shall be immediately exercisable and vested in full as of the date ten (10) days prior to the change in control, regardless of whether the option is assumed or substituted for by the acquirer.
Shares will become exercisable in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Outside Director's continuous service on Issuer's Board of Directors.
/s/ Friedhelm Blobel, Attorney-in-Fact For: Nancy T. Chang
2016-09-29